RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
British Medical Journal NHS Channel

subscribe to NHS newsletter
Healthcare : UK : NHS

   EMAIL   |   PRINT
Should EU patient information laws be relaxed?

Mar 30, 2007 - 2:07:46 AM , Reviewed by: Dr. Rashmi Yadav
"Relevant, comparative and appropriate information on health issues cannot be provided by drug companies.”

[RxPG] In 2002 the European parliament voted resoundingly against allowing drug companies to provide information about their products directly to patients. However, five years on, this decision is set to be challenged again.

A special report in this week’s BMJ looks at the arguments.

Hard lobbying by the drug industry has convinced EU health commissioners that increasing the extent to which drug companies can provide information to patients is essential to stop Europe’s drug industry falling further behind those of the United States and Japan. Drug companies also assert that this change would benefit patients.

But health campaign groups insist that drug companies cannot provide the independent information consumers need.

The commission will set out its final position next month, but speculation is already rife that it is likely to suggest changes to legislation that would jeopardise the current ban on direct to consumer advertising for prescription drugs.

Campaigners are particularly concerned that if the commission decides it needs to relax the laws then direct to consumer advertising would be introduced almost as a side effect.

Despite assurances that blatant advertising is not the intention, Barbara Mintzes of the University of British Columbia disagrees, saying that any change in the law to allow industry to provide information could produce undesirable effects – even if the advertising ban remains in place.

Rita Kessler of the campaign group AIM agrees. She believes that the current proposals would result in poor quality information and questions the need for more health information. She suggests that the commission should instead endorse an EU logo mark that would be awarded to high quality information sources and act as a quality stamp to help patients identify reliable, evidence based advice.

In anticipation of the commission’s final report in April, five international health associations have joined forces to step up their opposition campaign. They assert that “relevant, comparative and appropriate information on health issues cannot be provided by drug companies,” because in a competitive marketplace, dug companies must present their own products in a more favourable light than other preventive or therapeutic options.

However, the quick turnaround of MEPs means that few of the original objectors from 2002 remain in office – and that could mean a completely different outcome when patient information laws are debated again.

Publication: British Medical Journal
On the web: http://www.bmj.com/ 

Advertise in this space for $10 per month. Contact us today.

Related NHS News

Subscribe to NHS Newsletter

Enter your email address:

 About Dr. Rashmi Yadav
This news story has been reviewed by Dr. Rashmi Yadav before its publication on RxPG News website. Dr. Rashmi Yadav, MBBS, is a senior editor for RxPG News. In her position she is responsible for managing special correspondents and the surgery section of the website. Her areas of special interest include cardiothoracic surgery and interventional radiology.
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)